65,437 trials
Migraine
Primary: Percentage of Participants Who Are Headache Pain Free In High Dose Group (200 mg Lasmiditan) — 16.6; 40.8 percentage of participants — p=<0.001
Attention Deficit Disorder · Attention Deficit Hyperactivity Disorder
Primary: Change From Baseline in ADHD Investigator Symptom Rating Scale (AISRS) — -10.1; -9.73; -6.98 score on a scale — p==0.0193
Acute Upper Respiratory Tract Infections
Primary: Number of Participants That Filled a Prescription in 20 Days — 16; 16 Participants — p=0.924
Postoperative Pain · Hernia · Surgery
Primary: Pain Intensity on Movement — 3.4; 2.7; 3.9 score on a scale — p=0.0031
Amyotrophic Lateral Sclerosis
Primary: Change From Baseline in the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) Score — 39.8; -1.3; -2.5; -5.0 units on scale
Weight Loss
Primary: Weight — 214.7; 215.4 lbs
Femoral Arteriotomy Closure
Primary: Time to Hemostasis — 50 seconds
Dry Eye
Primary: Change in Fluorescein Corneal Staining (FCS) Score From Baseline — -3.3; -2.0; -2.9 score on a scale — p=<0.001
Anticoagulant Therapy
Primary: Accuracy of Factor Xa and Thrombin Inhibitors Pads of DOAC Dipstick From Urine Samples — 0.973; 0.993 percentage of correct responses — p=<0.05
Non-small Cell Lung Cancer
Primary: Number of Participants With Dose Limiting Toxicity — 1; 1; 1 Participants
Cancer
Primary: Quality of Life : EORTC QLQ-C30 Scores — 61.0; 70.8; 82.9; 83.2 scores on a scale
Diabetic Nephropathies
Primary: Ratio of UACR at Day 90 to UACR at Baseline — 0.869; 0.89; 0.824; 0.739 Ratio — p=0.1973
Ketogenic Dieting · Healthy
Primary: Changes to Body Fat Percentage as Assessed by DEXA Scan From Baseline to Day 70 Following Nic's Keto Diet — -2.25 percentage of body fat
Pain, Postoperative
Primary: Heft Parker Visual Analog Scale Pain Scale Pain Measurements — 63; 60 units on a scale
Minimal Change Disease
Primary: Percentage of Participants Achieving Complete Remission From Nephrotic Syndrome at 8 Weeks — 21; 17 Participants — p=0.12